Lomecel-B Effects on Alzheimer's Disease

NCT05233774 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Alzheimer's Disease

Interventions

DRUG: Allogeneic MSC
OTHER: Placebo

Sponsor

Longeveron Inc.

Collaborators

[object Object]